International Trade Bulletin - Volume 1, Issue 1
Client Alert | 2 min read | 03.20.06
Inside this issue:
- CHINA IN THE SPOTLIGHT
- EUROPE IN THE SPOTLIGHT
- DUTY RECOVERY : Many importers and manufacturers pay unnecessary duty on imported merchandise, either directly or as a cost of procured materials
- BILATERAL TRADE: The proposed U.S. – Korea FTA will be the most commercially significant FTA the U.S. has negotiated since NAFTA
- FOREIGN INVESTMENTS: New Indian investment rules allow foreign retailers to set up majority-owned stores in India – a high-growth market eyed by foreign retailers for years
- AIR TRANSPORT: Controversial U.S. DOT proposal to attract investment in the U.S. Airlines draws fire from both sides of the pond rather than hope for Open Skies
- SANCTIONS: The Office of Foreign Assets Control (“OFAC”) of the U.S. Department of the Treasury has issued an interim final rule outlining a new set of enforcement procedures
- NAFTA: NAFTA provisions on “regional value content” (RVC) calculation causes serious problems for related parties
- DUTY SUSPENSION: The Miscellaneous Tariff Bill (MTB) may be more relevant to your business than it sounds - at least if you are an importer of products that American factories do not produce domestically
- INTERNATIONAL IP PROTECTION: Elements of India’s new patent law which took effect in 2005 have prevented Novartis from obtaining a patent for its cancer drug “Gleevec”
Contacts
Insights
Client Alert | 5 min read | 04.23.26
CMS Proposes New Payment Policy for IOPOs and HCLs
In keeping with ongoing efforts to intensify regulatory oversight of organ procurement organizations (OPOs) and curtail improper spending within federal health programs, the Centers for Medicare & Medicaid Services (CMS) recently issued a proposed rule that would, among other adjustments, align Medicare payment policies for non-renal organs to be consistent with those currently applicable to kidneys. If enacted as drafted, this latest rule could have a direct impact on the financial stability of OPOs and histocompatibility laboratories (HCL) at a time when such organizations face increasing pressure to meet CMS’s new outcome measures — or else face non-renewal or decertification later this year.
Client Alert | 3 min read | 04.23.26
Crowell Tracker of Court Rulings on Legal Privilege and Artificial Intelligence Tools
Client Alert | 2 min read | 04.23.26
Two Lawsuits in One: The Growing Risk of Pairing Biometric Tech With Wage-and-Hour Violations
Client Alert | 3 min read | 04.22.26
